MDT
100.48
+1.87%↑
A
139.65
+3%↑
VEEV
219.8
+1.79%↑
HQY
84.32
+0.78%↑
NEOG
9.86
+5.45%↑
MDT
100.48
+1.87%↑
A
139.65
+3%↑
VEEV
219.8
+1.79%↑
HQY
84.32
+0.78%↑
NEOG
9.86
+5.45%↑
MDT
100.48
+1.87%↑
A
139.65
+3%↑
VEEV
219.8
+1.79%↑
HQY
84.32
+0.78%↑
NEOG
9.86
+5.45%↑
MDT
100.48
+1.87%↑
A
139.65
+3%↑
VEEV
219.8
+1.79%↑
HQY
84.32
+0.78%↑
NEOG
9.86
+5.45%↑
MDT
100.48
+1.87%↑
A
139.65
+3%↑
VEEV
219.8
+1.79%↑
HQY
84.32
+0.78%↑
NEOG
9.86
+5.45%↑
24h
Current
Min
4.28
Max
4.62
Recommendations | Buy |
|---|---|
12 Months Forecast | +177.78% upside |
Next Earnings | 5 Mar 2026 |
|---|
By Acuity
41%
59%
149 / 360 Healthcare
By Trading Central
Confidence
Weak Bearish Evidence
7.245 / 7.64 Support & Resistance
Past performance is not a reliable indicator of future results.
12 Jan 2026, 15:39 UTC
Atara Biotherapeutics Stock Falls After Surprise FDA Refusal to Approve Ebvallo
DJ
Read
7 Mar 2025, 21:54 UTC
Atara Biotherapeutics to Cut Half of Workforce Amid Restructuring
DJ
Read
Price change
By TipRanks
12 Months Forecast
Average 12 USD 177.78%
High 18 USD
Low 6 USD
Based on 2 Wall Street analysts offering 12 month price targets forAtara Biotherapeutics Inc - Dist in the last 3 months.
By TipRanks
Buy
2 ratings
1
Buy
1
Hold
0
Sell
Based on 2 analysts giving stock ratings to Atara Biotherapeutics Inc - Dist in the past 3 months.
By Trading Central
Short Term
Weak Bearish Evidence
Recent bearish events outweigh bullish events.
Intermediate Term
Strong Bullish Evidence
Recent bullish events outweigh bearish events.
Long Term
Bearish Evidence
All events are bearish.
By Acuity
News Sentiment
Bullish Evidence
Volatility
Below average
News Volume (RCV)
Below average
$